RSS Feed For (NASDAQ:MRNA)

MDRNA (NASDAQ:MRNA)

0.82 0.03 (3.53%)
MDRNA (NASDAQ:MRNA) Delayed :
Previous Close $0.85    52 Week High $3.55 
Open $0.82    52 Week Low $0.21 
Day High $0.84    P/E N/A 
Day Low $0.80    EPS $-0.54 
Volume 211,120       
More MRNA Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
SYMC 4 EFUT 4
GRH 3 PAR 3
SAY 3 LEA 3
DISK 3 PERY 3
DRIV 3 ALVR 3
AXL 3 FCEL 3
View All Friends, Peers and Foes

StreetInsider.com Major News for MRNA

Nov 12, 2009 04:08 PM MDRNA (MRNA) Reports Q3 Loss of $0.17
Jul 29, 2009 05:20 PM MDRNA (MRNA) Reports Q2 Loss of $0.21

StreetInsider Reports on MRNA by Category

View All Comments Comments on recent MRNA articles

JIMMY T
on Nov 11, 2009
at 10:53 AM
OPINION SOMETIMES DO COUNT(MRNA) http://www.medicalnewstoday.com/youropinions.php?opinionid=43299 REALITY IS HARD TO SWALLOW SOMETIMES GOOD LUCK TO 'MRNA' SHAREHOLDERS AND I HOPE THEY WAKE UP SOON!
Article: MDRNA (MRNA) Reports on DiLA2's Delivery of UsiRNA to Tumors in Vivo
JIMMY T
on Sep 8, 2009
at 10:38 AM
UPDATE:SEPTEMBER 8TH ON 'MRNA' THESTREET.COM HOT BIOTECHS NEXT WEEK:BIO BUZZ BY ADAM FEUERSTEIN Hot Biotech Events for Next Week: BioBuzz 09/04/09 - 07:50 AM EDT See All 2 Comments ELN , GERN , AGEN , BIIB , OSIR , GNTA.OB , VVUS Adam Feuerstein My comment to Adam, was why did he leave 'MRNA" out of his article? Below is his response for the entire HERD to read James - No slight intended by leaving out MDRNA. I'm sure you realize that dozens of companies are presenting next week. I can't mention them all. Re: MDRNA --I did see the CEO present last month at the Canaccord Adams conference, and let me say bluntly that he needs serious help with corporate messaging. I don't think I've ever sat through a more dense (and boring) investor presentation. I get it that RNAi isn't the easiest technology to explain simply, but the last thing I want at an investor conference is a 20-minute biochemistry lesson, which is what i heard. Seriously, there were people in the room falling asleep. ALWAYS NEWS ANNOUNCEMENTS, BUT DO THEY PRINT WHAT THEIR OWN WRITERS SAY ABOUT 'MRNA' WHEN ASKED A QUESTION.
Article: MDRNA, Inc. (MRNA) Reports Positive In Vivo Data Demonstrating That Its UsiRNAs Are Highly Potent Against Metabolic and Oncology Targets
jimmy T
on Aug 31, 2009
at 08:49 AM
ANALYSTS ON 'MRNA' AFTER THREE CONSECUTIVE YEARS OF BEING DEAD WRONG ON THEIR TARGET PRICES, THEY STILL ARE ISSUING A $4.00 TARGET PRICE. WHY? THESE PEOPLE SHOULD BE INVESTIGATED! CLOSED $1.40 FRIDAY. MRNA-TODAY AUG.31,2009 Bid: 1.35 x 500 Ask: 1.62 x 100
Article: MDRNA, Inc. (MRNA) Announces Full Repayment of GE Capital Debt
JIMMY T
on Aug 7, 2009
at 10:59 AM
MRNA(FEEDBACK)POSITIVE IN VIVO REPORT MRNA-AUG.7th- Nice news but still pre-clinical stage company. Repetative news, no earnings,no revenue, and 4-6 years away from possible approvals.That is why it is $1.48 up down stock price and channeling experts making profits, but it always was and still is a toture stock for any long investors.
Article: MDRNA, Inc. (MRNA) Reports Positive In Vivo Data Demonstrating That Its UsiRNAs Are Highly Potent Against Metabolic and Oncology Targets
Huron Ivestigation
on Aug 3, 2009
at 03:40 PM
Huron Consulting under investigation Hi All – Thought I’d provide a quick link for any investors reading this piece – I work for a law firm that’s investigating Huron on behalf of investors. You can learn more about the investigation here – www.hbsslaw.com/huron. HBSS is looking into possible issues with over-reported earnings, kickbacks to company insiders, and how and when the company notified shareholders.
Article: Morning Movers 8/3: KERX, TSPT, TSEM, ICAD, AMFI Higher; HURN, RPRX, ADAT, SVNT Lower
View All Comments

Comments on MRNA

JIMMY T
at Jul 12, 2008 07:50 AM
JULY 11 ARTICLE-BIOTECH MAILBAG THIS ARTICLE ONLY CONFIRMS MY JULY 2 POSTING ON STREETINSIDER.COM. IF YOU ALSO READ 'EARNINGSWHISPERS,THE STREET.COM., MONEY CENTRAL, PREDICTWALLSTREET, STOCKCONSULTANT,ETC., YOU WOULD WONDER WHAT THE HECK THE 'SEC' IS OVERLOOKING ON THIS ONE. THE LESSON TO BE LEARNED SHOULD BE TAUGHT AT EVERY FINANCIAL COLLEGE TO EVERY STUDENT ON HOW PERCEIVING A BELIEF CAN PUT YOU IN THE 'POOR HOUSE'.